142 related articles for article (PubMed ID: 25418912)
1. Human in Vivo Pharmacokinetics of [(14)C]Dibenzo[def,p]chrysene by Accelerator Mass Spectrometry Following Oral Microdosing.
Madeen E; Corley RA; Crowell S; Turteltaub K; Ognibene T; Malfatti M; McQuistan TJ; Garrard M; Sudakin D; Williams DE
Chem Res Toxicol; 2015 Jan; 28(1):126-34. PubMed ID: 25418912
[TBL] [Abstract][Full Text] [Related]
2. Human Microdosing with Carcinogenic Polycyclic Aromatic Hydrocarbons: In Vivo Pharmacokinetics of Dibenzo[def,p]chrysene and Metabolites by UPLC Accelerator Mass Spectrometry.
Madeen EP; Ognibene TJ; Corley RA; McQuistan TJ; Henderson MC; Baird WM; Bench G; Turteltaub KW; Williams DE
Chem Res Toxicol; 2016 Oct; 29(10):1641-1650. PubMed ID: 27494294
[TBL] [Abstract][Full Text] [Related]
3. In vitro metabolism of benzo[a]pyrene-7,8-dihydrodiol and dibenzo[def,p]chrysene-11,12 diol in rodent and human hepatic microsomes.
Smith JN; Mehinagic D; Nag S; Crowell SR; Corley RA
Toxicol Lett; 2017 Mar; 269():23-32. PubMed ID: 28119020
[TBL] [Abstract][Full Text] [Related]
4. Impact of pregnancy on the pharmacokinetics of dibenzo[def,p]chrysene in mice.
Crowell SR; Sharma AK; Amin S; Soelberg JJ; Sadler NC; Wright AT; Baird WM; Williams DE; Corley RA
Toxicol Sci; 2013 Sep; 135(1):48-62. PubMed ID: 23744095
[TBL] [Abstract][Full Text] [Related]
5. In vitro metabolism of benzo[a]pyrene and dibenzo[def,p]chrysene in rodent and human hepatic microsomes.
Crowell SR; Hanson-Drury S; Williams DE; Corley RA
Toxicol Lett; 2014 Jul; 228(1):48-55. PubMed ID: 24769260
[TBL] [Abstract][Full Text] [Related]
6. Toxicokinetics of benzo[a]pyrene in humans: Extensive metabolism as determined by UPLC-accelerator mass spectrometry following oral micro-dosing.
Madeen E; Siddens LK; Uesugi S; McQuistan T; Corley RA; Smith J; Waters KM; Tilton SC; Anderson KA; Ognibene T; Turteltaub K; Williams DE
Toxicol Appl Pharmacol; 2019 Feb; 364():97-105. PubMed ID: 30582946
[TBL] [Abstract][Full Text] [Related]
7. Analysis of dibenzo[def,p]chrysene-deoxyadenosine adducts in wild-type and cytochrome P450 1b1 knockout mice using stable-isotope dilution UHPLC-MS/MS.
Harper TA; Morré J; Lauer FT; McQuistan TJ; Hummel JM; Burchiel SW; Williams DE
Mutat Res Genet Toxicol Environ Mutagen; 2015 Apr; 782():51-6. PubMed ID: 25868132
[TBL] [Abstract][Full Text] [Related]
8. Translating dosimetry of Dibenzo[def,p]chrysene (DBC) and metabolites across dose and species using physiologically based pharmacokinetic (PBPK) modeling.
Pande P; Madeen EP; Williams DE; Crowell SR; Ognibene TJ; Turteltaub KW; Corley RA; Smith JN
Toxicol Appl Pharmacol; 2022 Mar; 438():115830. PubMed ID: 34933053
[TBL] [Abstract][Full Text] [Related]
9. Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [
Vermillion Maier ML; Siddens LK; Pennington JM; Uesugi SL; Anderson KA; Tidwell LG; Tilton SC; Ognibene TJ; Turteltaub KW; Smith JN; Williams DE
Environ Int; 2022 Jan; 159():107045. PubMed ID: 34920278
[TBL] [Abstract][Full Text] [Related]
10. Impact of phenanthrene co-administration on the toxicokinetics of benzo[a]pyrene in humans. UPLC-accelerator mass spectrometry following oral microdosing.
Maier MLV; Siddens LK; Pennington JM; Uesugi SL; Labut EM; Vertel EA; Anderson KA; Tidwell LG; Tilton SC; Ognibene TJ; Turteltaub KW; Smith JN; Williams DE
Chem Biol Interact; 2023 Sep; 382():110608. PubMed ID: 37369263
[TBL] [Abstract][Full Text] [Related]
11. Comparative mechanisms of PAH toxicity by benzo[a]pyrene and dibenzo[def,p]chrysene in primary human bronchial epithelial cells cultured at air-liquid interface.
Chang Y; Siddens LK; Heine LK; Sampson DA; Yu Z; Fischer KA; Löhr CV; Tilton SC
Toxicol Appl Pharmacol; 2019 Sep; 379():114644. PubMed ID: 31255691
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of [
Hummel JM; Madeen EP; Siddens LK; Uesugi SL; McQuistan T; Anderson KA; Turteltaub KW; Ognibene TJ; Bench G; Krueger SK; Harris S; Smith J; Tilton SC; Baird WM; Williams DE
Food Chem Toxicol; 2018 May; 115():136-147. PubMed ID: 29518434
[TBL] [Abstract][Full Text] [Related]
13. Preliminary physiologically based pharmacokinetic models for benzo[a]pyrene and dibenzo[def,p]chrysene in rodents.
Crowell SR; Amin SG; Anderson KA; Krishnegowda G; Sharma AK; Soelberg JJ; Williams DE; Corley RA
Toxicol Appl Pharmacol; 2011 Dec; 257(3):365-76. PubMed ID: 22001385
[TBL] [Abstract][Full Text] [Related]
14. Polycyclic aromatic hydrocarbons as skin carcinogens: comparison of benzo[a]pyrene, dibenzo[def,p]chrysene and three environmental mixtures in the FVB/N mouse.
Siddens LK; Larkin A; Krueger SK; Bradfield CA; Waters KM; Tilton SC; Pereira CB; Löhr CV; Arlt VM; Phillips DH; Williams DE; Baird WM
Toxicol Appl Pharmacol; 2012 Nov; 264(3):377-86. PubMed ID: 22935520
[TBL] [Abstract][Full Text] [Related]
15. Dibenzo[def,p]chrysene (DBC) suppresses antibody formation in spleen cells following oral exposures of mice.
Lauer FT; Walker MK; Burchiel SW
J Toxicol Environ Health A; 2013; 76(1):16-24. PubMed ID: 23151208
[TBL] [Abstract][Full Text] [Related]
16. A Highly Abbreviated Synthesis of Dibenzo[def,p]chrysene and Its 12-Methoxy Derivative, a Key Precursor for the Synthesis of the Proximate and Ultimate Carcinogens of Dibenzo[def,p]chrysene.
Sharma AK; Kumar S; Amin S
J Org Chem; 2004 May; 69(11):3979-82. PubMed ID: 15153038
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of dibenzo[def,p]chrysene, its active metabolites, and their 13C-labeled analogues.
Xu D; Duan Y; Blair IA; Penning TM; Harvey RG
Org Lett; 2008 Mar; 10(6):1059-62. PubMed ID: 18284245
[TBL] [Abstract][Full Text] [Related]
18. Tumor formation in the neonatal mouse bioassay indicates that the potent carcinogen dibenzo[def,p]chrysene (dibenzo[a,l]pyrene) is activated in vivo via its trans-11,12-dihydrodiol.
Platt KL; Dienes HP; Tommasone M; Luch A
Chem Biol Interact; 2004 Jun; 148(1-2):27-36. PubMed ID: 15223354
[TBL] [Abstract][Full Text] [Related]
19. Transplacental carcinogenesis with dibenzo[def,p]chrysene (DBC): timing of maternal exposures determines target tissue response in offspring.
Shorey LE; Castro DJ; Baird WM; Siddens LK; Löhr CV; Matzke MM; Waters KM; Corley RA; Williams DE
Cancer Lett; 2012 Apr; 317(1):49-55. PubMed ID: 22085489
[TBL] [Abstract][Full Text] [Related]
20. Dibenzo[a,l]pyrene (dibenzo[def,p]chrysene): fjord-region distortions.
Katz AK; Carrell HL; Glusker JP
Carcinogenesis; 1998 Sep; 19(9):1641-8. PubMed ID: 9771936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
